• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Pulmonary toxicity in patients treated with gemcitabine and a combination of gemcitabine and a taxane: investigation of a signal using postmarketing data.吉西他滨单药治疗以及吉西他滨与紫杉烷联合治疗患者的肺部毒性：利用上市后数据对信号进行调查。
Br J Cancer. 2006 Jun 5;94(11):1759-60. doi: 10.1038/sj.bjc.6603161.
2
Gemcitabine-taxane experience in the treatment of metastatic breast cancer.吉西他滨-紫杉烷联合治疗转移性乳腺癌的经验
Cancer Treat Rev. 2005;31 Suppl 4:S11-5. doi: 10.1016/s0305-7372(05)80003-9.
3
[Digital necrosis related to gemcitabine].[与吉西他滨相关的数字坏死]
Presse Med. 2010 Dec;39(12):1336-8. doi: 10.1016/j.lpm.2010.07.010. Epub 2010 Sep 17.
4
Gemcitabine combination chemotherapy in metastatic breast cancer: phase II experience.吉西他滨联合化疗用于转移性乳腺癌：II期经验。
Oncology (Williston Park). 2003 Dec;17(12 Suppl 14):15-21.
5
What is the best schedule for administration of gemcitabine-taxane?吉西他滨-紫杉烷联合用药的最佳给药方案是什么？
Cancer Treat Rev. 2005;31 Suppl 4:S23-8. doi: 10.1016/s0305-7372(05)80005-2.
6
Combination chemotherapy studies with gemcitabine.吉西他滨联合化疗研究。
Semin Oncol. 1997 Apr;24(2 Suppl 7):S7-17-S7-23.
7
Gemcitabine, anthracycline, and taxane combinations for advanced breast cancer.吉西他滨、蒽环类药物和紫杉烷类药物联合用于晚期乳腺癌
Oncology (Williston Park). 2003 Dec;17(12 Suppl 14):36-40.
8
[Gemcitabine and breast cancer].[吉西他滨与乳腺癌]
Bull Cancer. 2002 Aug;89 Spec No:S107-14.
9
In vitro interaction between gemcitabine and other anticancer drugs using a novel three-dimensional model.使用新型三维模型研究吉西他滨与其他抗癌药物的体外相互作用。
Semin Oncol. 1997 Apr;24(2 Suppl 7):S7-8-S7-16.
10
Gemcitabine in the management of metastatic breast cancer: a systematic review.吉西他滨用于转移性乳腺癌的治疗：一项系统评价
Breast Cancer Res Treat. 2008 Apr;108(3):319-31. doi: 10.1007/s10549-007-9610-z. Epub 2007 May 26.

引用本文的文献

1
Interstitial lung disease associated with gemcitabine treatment in patients with non-small-cell lung cancer and pancreatic cancer.吉西他滨治疗非小细胞肺癌和胰腺癌相关的间质性肺疾病。
J Cancer Res Clin Oncol. 2011 Oct;137(10):1469-75. doi: 10.1007/s00432-011-1013-1. Epub 2011 Aug 5.
2
A case of late-onset gemcitabine lung toxicity.一例吉西他滨迟发性肺毒性。
Clin Med Insights Oncol. 2011;5:171-6. doi: 10.4137/CMO.S6643. Epub 2011 May 29.
3
Locally advanced breast cancer: pulmonary toxicity secondary to gemcitabine.局部晚期乳腺癌：吉西他滨引起的肺毒性。
Clin Transl Oncol. 2010 Jun;12(6):450-2. doi: 10.1007/s12094-010-0533-5.
4
Fatal gemcitabine-induced pulmonary toxicity in metastatic gallbladder adenocarcinoma.转移性胆囊腺癌致致命吉西他滨肺毒性
Cancer Chemother Pharmacol. 2010 Feb;65(3):607-10. doi: 10.1007/s00280-009-1167-6.

本文引用的文献

1
SCOTROC 2A: carboplatin followed by docetaxel or docetaxel-gemcitabine as first-line chemotherapy for ovarian cancer.SCOTROC 2A研究：卡铂序贯多西他赛或多西他赛-吉西他滨作为卵巢癌一线化疗方案
Br J Cancer. 2006 Jan 16;94(1):62-8. doi: 10.1038/sj.bjc.6602909.
2
A phase II feasibility study of carboplatin followed by sequential weekly paclitaxel and gemcitabine as first-line treatment for ovarian cancer.一项关于卡铂随后序贯每周紫杉醇和吉西他滨作为卵巢癌一线治疗的II期可行性研究。
Br J Cancer. 2004 Aug 16;91(4):627-32. doi: 10.1038/sj.bjc.6602000.
3
A phase II study of weekly gemcitabine and paclitaxel in patients with previously untreated stage IIIb and IV non-small cell lung cancer.一项针对既往未接受治疗的 IIIb 期和 IV 期非小细胞肺癌患者的吉西他滨与紫杉醇周疗的 II 期研究。
Lung Cancer. 2002 Oct;38(1):73-7. doi: 10.1016/s0169-5002(02)00145-9.
4
Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports.使用比例报告比（PRR）从自发药物不良反应报告中生成信号。
Pharmacoepidemiol Drug Saf. 2001 Oct-Nov;10(6):483-6. doi: 10.1002/pds.677.
5
Gemcitabine and paclitaxel associated pneumonitis in non-small cell lung cancer: report of a phase I/II dose-escalating study.吉西他滨与紫杉醇联合治疗非小细胞肺癌相关性肺炎：一项I/II期剂量递增研究报告
Eur J Cancer. 2000 Dec;36(18):2329-34. doi: 10.1016/s0959-8049(00)00341-5.

Pulmonary toxicity in patients treated with gemcitabine and a combination of gemcitabine and a taxane: investigation of a signal using postmarketing data.

作者信息

Czarnecki A, Voss S

出版信息

Br J Cancer. 2006 Jun 5;94(11):1759-60. doi: 10.1038/sj.bjc.6603161.

DOI:10.1038/sj.bjc.6603161
PMID:16685265
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2361299/
Abstract
摘要